Orphan drug for type 1 diabetes stem cell therapy
October 26, 2022 Category :Diabetes Facts 0
An orphan drug designation for a stem cell therapy (Prochymal; Osiris Therapeutics Inc.) in patients with newly diagnosed type 1 diabetes mellitus has recently been approved by the U.S. Food and Drug Administration.
Related terms:
- type 1 diabetes n orphan disease
- type 1 diabetes orphan
- Osiris and Type1 Diabetes and
- orphan disease diabetes type ii
- Osiris and Type1 Diabetes and 2011
- Osiris and Type1 Diabetes
- type I diabetes is orphan
- orphan drug mesenchymal stem cells
- orphan drug for type 1 diabetes
- orphan drug diabetes melitus
- orphan drug diabetes
- diabetes and orphan drugs
- orphan disease diabetes
- orphan disease and type 1diabetes
- fda orphan drugs status prevention of graft versus host disease
- FDA Approves Orphan Drug Status for Type 1 Diabetes Stem Cell Therapy
- elwin fernando diabetes
- drug orphan for diabetes
- diabetes orphan drug indication
- diabetes orphan drug